Product complaint # (b)(4).The device catalog number is unknown; therefore, udi is unavailable.Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
Literature article reviewed.Mahylis jm, puzzitiello rn, ho jc, amini mh, iannotti jp, ricchetti et.Comparison of radiographic and clinical outcomes of revision reverse total shoulder arthroplasty with structural versus nonstructural bone graft.J shoulder elbow surg.28 jan 2019.Pmid: 30201217.The article's purpose was to compare radiographic and clinical results of patients requiring structural iliac crest bone autograft (icba) for severe bone loss versus patients with less severe bone loss treated with nonstructural bone allograft (nsba) in the setting of revision reverse total shoulder arthroplasty (rsa).Patient data: 67.4 mean age, 46.6% female.Depuy products: depuy delta xtend in 21 patients, competitor constructs were also utilized in 9 patients.Adverse events (n = number of impacted patients is not clear within the article).(n) metaglene malpositioning ¿ treatment not noted.(n) scapular notching ¿ treatment not noted.(1) shoulder dislocation ¿ closed reduction (2) glenoid baseplate migration ¿ conservative treatment.(1) glenoid loosening ¿ treatment not noted.(1) infection ¿ 2 stage revision.
|